Deutsch English Français

Contact

EP2435432

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2435432

EP2435432 - APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES [Right-click to bookmark this link]
Status	The patent has been limited Status updated on 22.09.2023 Database last updated on 05.10.2024
Most recent event Tooltip	10.05.2024	Lapse of the patent in a contracting state	published on 12.06.2024 [2024/24]
Applicant(s)	For all designated states AbbVie Ireland Unlimited Company c/o Conyers Corporate Service (Bermuda) Limited Clarendon House 2 Church Street Hamilton HM11 / BM
	[2023/43]
Former [2014/04]	For all designated states AbbVie Bahamas Ltd. Sassoon House Shirley Street & Victoria Avenue New Providence, Nassau / BS
Former [2012/14]	For all designated states Abbott Laboratories 100 Abbott Park Rd. Abbott Park, IL 60064 / US
Inventor(s)	01 / BRUNCKO, Milan 31231 Prairie Ridge Green Oaks Illinois 60048 / US
	02 / DING, Hong 7465 Clem Drive Gurnee Illinois 60031 / US
	03 / DOHERTY, George 1605 Bush Court Libertyville Illinois 60048 / US
	04 / ELMORE, Steven 239 Ash Lane Northbrook Illinois 60062 / US
	05 / HASVOLD, Lisa 522 Shakespeare Drive Grayslake Illinois 60030 / US
	06 / HEXAMER, Laura 439 Gatewood Lane Grayslake Illinois 60030 / US
	07 / KUNZER, Aaron R. 615 W. Burr Oak Drive Arlington Illinois 60004 / US
	08 / SONG, Xiaohong 34037 Sulkey Drive Grayslake Illinois 60030 / US
	09 / SOUERS, Andrew J. 901 Hinman Apt. 3A Evanston Illinois 60202 / US
	10 / SULLIVAN, Gerard 1212 Tulip Tree Court Lake Villa Illinois 60046 / US
	11 / TAO, Zhi-Fu 1532 Vineyard Drive Gurnee Illinois 60031 / US
	12 / WANG, Gary T. 1904 Darnell Street Libertyville Illinois 60048 / US
	13 / WANG, Le 338 East Colonial Drive Vernon Hills Illinois 60061 / US
	14 / WANG, Xilu 1617 Eric Lane Libertyville Illinois 60048 / US
	15 / WENDT, Michael 1445 Maidstone Drive Vernon Hills Illinois 60061 / US
	16 / MANTEI, Robert 4203 Carolyn Court Franklin Wisconsin 53132 / US
	17 / HANSEN, Todd M. 191Seymour Avenue Grayslake Illinois 60030 / US
	[2012/35]
Former [2012/14]	01 / BRUNCKO, Milan 31231 Prairie Ridge Green Oaks Illinois 60048 / US
	02 / DING, Hong 7465 Clem Drive Gurnee Illinois 60031 / US
	03 / DOHERTY, George 1605 Bush Court Libertyville Illinois 60048 / US
	04 / ELMORE, Steven 239 Ash Lane Northbrook Illinois 60062 / US
	05 / HASVOLD, Lisa 522 Shakespeare Drive Grayslake Illinois 60030 / US
	06 / HEXAMER, Laura 439 Gatewood Lane Grayslake Illinois 60030 / US
	07 / KUNZER, Aaron R. 615 W. Burr Oak Drive Arlington Illinois 60004 / US
	08 / SONG, Xiaohong 34037 Sulkey Drive Grayslake Illinois 60030 / US
	09 / SOUERS, Andrew J. 901 Hinman Apt. 3A Evanston Illinois 60202 / US
	10 / SULLIVAN, Gerard 1212 Tulip Tree Court Lake Villa Illinois 60046 / US
	11 / TAO, Zhi-Fu 1532 Vineyard Drive Gurnee Illinois 60031 / US
	12 / WANG, Gary T. 1904 Darnell Street Libertyville Illinois 60048 / US
	13 / WANG, Le 338 East Colonial Drive Vernon Hills Illinois 60061 / US
	14 / WANG, Xilu 34056 Sulkey Drive Grayslake Illinois 60030 / US
	15 / WENDT, Michael 1445 Maidstone Drive Vernon Hills Illinois 60061 / US
	16 / MANTEI, Robert 4203 Carolyn Court Franklin Wisconsin 53132 / US
	17 / HANSEN, Todd M. 191Seymour Avenue Grayslake Illinois 60030 / US
Representative(s)	Miller, David James, et al Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB
	[2023/43]
Former [2015/26]	Miller, David James, et al Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB
Former [2012/14]	Miller, David James, et al Mathys & Squire LLP 120 Holborn London EC1N 2SQ / GB
Application number, filing date	10721246.6	26.05.2010
	[2023/43]
	WO2010US36198
Priority number, date	US20090181203P	26.05.2009 Original published format: US 181203 P
	[2012/14]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2010138588
	Date:	02.12.2010
	Language:	EN
	[2010/48]
	Type:	A2 Application without search report
	No.:	EP2435432
	Date:	04.04.2012
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 02.12.2010 takes the place of the publication of the European patent application.
	[2012/14]
	Type:	B1 Patent specification
	No.:	EP2435432
	Date:	24.06.2015
	Language:	EN
	[2015/26]
	Type:	B3 Limited patent
	No.:	EP2435432
	Date:	25.10.2023
	Language:	EN
	[2023/43]
Search report(s)	International search report - published on:	EP	07.04.2011
	Supplementary international search report - requested on:	RU	03.12.2010
Classification	IPC:	C07D471/04	[2012/14]
	CPC:	C07D471/04 (EP,CN,IL,KR,RU,US); A61K31/437 (KR,RU); A61K31/496 (RU); A61P31/18 (EP,IL); A61P35/00 (EP,IL,KR); A61P35/02 (EP,IL); (+) A61P37/00 (EP,IL); A61P37/02 (EP,IL); A61P37/06 (EP,IL); A61P43/00 (EP,IL); C07D403/14 (RU); C07D491/052 (IL,US); C07D519/00 (CN,IL,US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/14]
Extension states	BA	22.12.2011
	ME	22.12.2011
	RS	22.12.2011
Title	German:	APOPTOSEINDUKTOREN FÜR DIE BEHANDLUNG VON KREBS SOWIE IMMUN- UND AUTOIMMUNERKRANKUNGEN	[2012/14]
	English:	APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES	[2012/14]
	French:	AGENTS INDUISANT L'APOPTOSE, DANS LE TRAITEMENT DU CANCER ET DE MALADIES IMMUNES ET AUTO-IMMUNES	[2012/14]
Entry into regional phase	22.12.2011	National basic fee paid
	22.12.2011	Designation fee(s) paid
	22.12.2011	Examination fee paid
Examination procedure	22.12.2011	Examination requested [2012/14]
	31.07.2012	Amendment by applicant (claims and/or description)
	06.06.2013	Despatch of a communication from the examining division (Time limit: M06)
	16.12.2013	Reply to a communication from the examining division
	22.05.2014	Communication of intention to grant the patent
	05.09.2014	Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
	01.10.2014	Communication of intention to grant the patent
	11.02.2015	Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
	03.03.2015	Communication of intention to grant the patent
	14.05.2015	Fee for grant paid
	14.05.2015	Fee for publishing/printing paid
	14.05.2015	Receipt of the translation of the claim(s)
Divisional application(s)	EP15167892.7 / EP2944638
	EP19195104.5 / EP3656771
	EP24195253.0
	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 06.06.2013
Opposition(s)	29.03.2016	No opposition filed within time limit [2016/22]
Limitations:	13.03.2023	Date of receipt of request for limitation
		admissible
	09.06.2023	Communication of intention to limit the patent
	15.09.2023	Fee for printing patent specification after limitation
Fees paid	Renewal fee
	21.03.2012	Renewal fee patent year 03
	26.03.2013	Renewal fee patent year 04
	26.03.2014	Renewal fee patent year 05
	07.05.2015	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	SK	24.06.2015
	[2024/24]
Cited in	International search	[A]RU2001103044 ;
		[A]RU2239631 ;
		[A]RU2004130280
	International search	[I]US2007015787 (BRUNCKO MILAN [US], et al)
	by applicant	WO9507271
		WO9710223
		WO2005024636
		WO2005049593
		WO2005099353
		WO2006008754
		US2009082471
		US7511013
		US2009088416
		US7514068
		US2009093422
		US7521421
		US2009105338
		US2009105307
		US2009105147
		US2009111840
		US7528131
		US2009118238
		US7531685
		US7534814
		US2009131485
		US2009131363
		US7538189
		US2009137457
		US20070988479
		US20070941196
		US20090631404

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p